Categories: The Commercial Chemist | No Comments
Clean technology and life science companies in the US have been reaping the rewards of increasing investment from venture capitalists (VCs) in the first half of 2010, according to the MoneyTree report from consultancy firm PricewaterhouseCoopers and the National Venture Capital association (NVCA). More than $11.4 billion (£7.5 billion) was invested in the first 6 months of the year – a 49 per cent increase compared to the first half of 2009 when only $7.7 billion was invested.
Investment in clean technologies doubled in the second quarter of 2010 compared to the first 3 months of the year – breaking the quarterly record for the sector and reaching $1.5 billion. Life sciences companies saw VC investment increase 52 per cent to $2.1 billion compared to the first quarter of the year.
‘As the exit market begins to show signs of life, VCs are now able to look increasingly at new investments outside their existing portfolio. This dynamic translates into momentum in the seed and early stage sectors where valuations remain reasonable and opportunities are great,’ says Mark Heesen, president of NVCA.
‘Investment in the clean technology and life sciences sectors, which are generally longer term and more capital intensive in nature, are balanced by smaller deals within the information technology sectors creating a diversity of opportunities for success for entrepreneurs, VCs and limited partners alike.’ (more…)